These data demonstrate that combined knockdown of p110α and Vps34 using siRNA can induce caspase and PARP cleavage, and enhance lapatinib-mediated growth inhibition in HER2+ breast cancer cells, consistent with what was seen using EZN4150. This evidence concerns the gene ERBB2 and breast carcinoma.